Pathogenesis of lysosomal storage disorders as illustrated by Gaucher disease.

Suppr

超能文献

作者信息

Aerts J M, Van Weely S, Boot R, Hollak C E, Tager J M

机构信息

E.C. Slater Institute for Biochemical Research, University of Amsterdam, The Netherlands.

出版信息

J Inherit Metab Dis. 1993;16(2):288-91. doi: 10.1007/BF00710267.

DOI:10.1007/BF00710267

PMID:8411983

Abstract

摘要

相似文献

Pathogenesis of lysosomal storage disorders as illustrated by Gaucher disease.

J Inherit Metab Dis. 1993;16(2):288-91. doi: 10.1007/BF00710267.

Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.溶酶体贮积症与帕金森病：戈谢病及其他。

Mov Disord. 2011 Aug 1;26(9):1593-604. doi: 10.1002/mds.23774. Epub 2011 May 26.

Perspective: Finding common ground.观点：寻求共识。

Nature. 2016 Sep 22;537(7621):S160-1. doi: 10.1038/537S160a.

Gaucher disease: a lysosomal neurodegenerative disorder.戈谢病：一种溶酶体神经退行性疾病。

Eur Rev Med Pharmacol Sci. 2015 Apr;19(7):1219-26.

Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases.戈谢病及其他溶酶体贮积病中生物标志物的鉴定与应用。

Acta Paediatr Suppl. 2005 Mar;94(447):43-6; discussion 37-8. doi: 10.1111/j.1651-2227.2005.tb02110.x.

Recapture Lysosomal Enzyme Deficiency via Targeted Gene Disruption in the Human Near-Haploid Cell Line HAP1.通过靶向基因敲除人近单倍体细胞系 HAP1 中的溶酶体酶缺陷来恢复。

Genes (Basel). 2021 Jul 15;12(7):1076. doi: 10.3390/genes12071076.

Ambroxol improves skeletal and hematological manifestations on a child with Gaucher disease.氨溴索改善戈谢病患儿的骨骼和血液学表现。

J Hum Genet. 2020 Mar;65(3):345-349. doi: 10.1038/s10038-019-0704-3. Epub 2019 Dec 11.

Is Parkinson's disease a lysosomal disorder?帕金森病是否是溶酶体疾病？

Brain. 2018 Aug 1;141(8):2255-2262. doi: 10.1093/brain/awy147.

[Treatment prospects of lysosomal storage disorders].[溶酶体贮积症的治疗前景]

Orv Hetil. 2008 Jun 22;149(25):1171-9. doi: 10.1556/OH.2008.28382.

Emerging links between pediatric lysosomal storage diseases and adult parkinsonism.儿科溶酶体贮积症与成人帕金森病之间新出现的联系。

Mov Disord. 2019 May;34(5):614-624. doi: 10.1002/mds.27631. Epub 2019 Feb 6.

引用本文的文献

Role of the Lactide:Glycolide Ratio in PLGA Nanoparticle Stability and Release under Lysosomal Conditions for Enzyme Replacement Therapy of Lysosomal Storage Disorders.丙交酯与乙交酯比例在聚乳酸-羟基乙酸共聚物纳米颗粒稳定性及溶酶体条件下释放中的作用，用于溶酶体贮积症的酶替代疗法

J Funct Biomater. 2023 Aug 25;14(9):440. doi: 10.3390/jfb14090440.

Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies.溶酶体贮积症诊断中的生物标志物：蛋白质、脂质和抑制物。

J Inherit Metab Dis. 2011 Jun;34(3):605-19. doi: 10.1007/s10545-011-9308-6. Epub 2011 Mar 29.

Substrate reduction therapy of glycosphingolipid storage disorders.鞘糖脂贮积症的底物减少疗法。

J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):449-56. doi: 10.1007/s10545-006-0272-5.

Biochemistry of glycosphingolipid storage disorders: implications for therapeutic intervention.糖鞘脂贮积症的生物化学：对治疗干预的影响

Philos Trans R Soc Lond B Biol Sci. 2003 May 29;358(1433):905-14. doi: 10.1098/rstb.2003.1273.

Oligosaccharide excretion in adult Gaucher disease.

J Inherit Metab Dis. 1998 Feb;21(1):49-59. doi: 10.1023/a:1005311430722.

A case of type I Gaucher disease with cardiopulmonary amyloidosis and chitotriosidase deficiency.1型戈谢病合并心肺淀粉样变性和壳三糖苷酶缺乏症1例。

Virchows Arch. 1996 Nov;429(4-5):305-9. doi: 10.1007/BF00198347.

本文引用的文献

METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.葡萄糖脑苷脂的代谢。II. 戈谢病中酶缺乏的证据。

Biochem Biophys Res Commun. 1965 Jan 18;18:221-5. doi: 10.1016/0006-291x(65)90743-6.

Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease.pH在决定1型戈谢病中葡萄糖脑苷脂酶细胞类型特异性残余活性方面的作用。

J Clin Invest. 1993 Mar;91(3):1167-75. doi: 10.1172/JCI116276.

The occurrence of psychosine and other glycolipids in spleen and liver from the three major types of Gaucher's disease.三种主要类型戈谢病患者脾脏和肝脏中鞘氨醇半乳糖苷及其他糖脂的出现情况。

Biochim Biophys Acta. 1982 Sep 14;712(3):453-63. doi: 10.1016/0005-2760(82)90272-7.

Gaucher cells in chronic myelocytic leukemia: an acquired abnormality.

Blood. 1969 Feb;33(2):379-90.

Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA.人葡萄糖脑苷脂酶cDNA的分子克隆及核苷酸序列

Proc Natl Acad Sci U S A. 1985 Nov;82(21):7289-93. doi: 10.1073/pnas.82.21.7289.

Gene mapping and leader polypeptide sequence of human glucocerebrosidase: implications for Gaucher disease.人类葡萄糖脑苷脂酶的基因定位与前导多肽序列：对戈谢病的意义

Proc Natl Acad Sci U S A. 1985 Oct;82(20):7101-5. doi: 10.1073/pnas.82.20.7101.

Gaucher disease: genetic heterogeneity within and among the subtypes detected by immunoblotting.戈谢病：通过免疫印迹法检测到的各亚型内部及之间的基因异质性。

Am J Hum Genet. 1987 Jan;40(1):15-31.

Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts.戈谢病成纤维细胞中葡萄糖脑苷脂酶的生物合成与成熟

Eur J Biochem. 1987 Apr 1;164(1):171-9. doi: 10.1111/j.1432-1033.1987.tb11008.x.

Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses.溶血鞘脂抑制蛋白激酶C：对鞘脂贮积症的影响。

Science. 1987 Feb 6;235(4789):670-4. doi: 10.1126/science.3101176.

The human glucocerebrosidase gene and pseudogene: structure and evolution.人类葡萄糖脑苷脂酶基因与假基因：结构与进化

Genomics. 1989 Jan;4(1):87-96. doi: 10.1016/0888-7543(89)90319-4.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验